Title |
Should we screen for type 2 diabetes among asymptomatic individuals? Yes
|
---|---|
Published in |
Diabetologia, August 2017
|
DOI | 10.1007/s00125-017-4397-x |
Pubmed ID | |
Authors |
David Simmons, Janice C. Zgibor |
Abstract |
RCTs of whether screening asymptomatic individuals for undiagnosed diabetes results in reduced mortality or has other benefits have been suggestive, but inconclusive. In this issue of Diabetologia, two additional controlled studies (DOIs: 10.1007/s00125-017-4323-2 and 10.1007/s00125-017-4299-y ) that investigated whether screening for type 2 diabetes in asymptomatic individuals is associated with a reduction in mortality are presented. Treating diabetes early, and identifying and treating impaired glucose tolerance, are of benefit, and economic modelling indicates such screening is cost-effective. Now that such screening is already underway in many countries, new data, along with the existing evidence, suggests opportunistic screening is the best way forward. More research is needed, however, on how best to screen and how to improve risk-factor control once dysglycaemia is detected. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 9 | 43% |
Spain | 3 | 14% |
United States | 2 | 10% |
Germany | 1 | 5% |
India | 1 | 5% |
Unknown | 5 | 24% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 14 | 67% |
Practitioners (doctors, other healthcare professionals) | 4 | 19% |
Scientists | 2 | 10% |
Science communicators (journalists, bloggers, editors) | 1 | 5% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 29 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 8 | 28% |
Student > Ph. D. Student | 7 | 24% |
Researcher | 4 | 14% |
Professor > Associate Professor | 2 | 7% |
Other | 1 | 3% |
Other | 1 | 3% |
Unknown | 6 | 21% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 13 | 45% |
Nursing and Health Professions | 3 | 10% |
Computer Science | 2 | 7% |
Pharmacology, Toxicology and Pharmaceutical Science | 1 | 3% |
Environmental Science | 1 | 3% |
Other | 2 | 7% |
Unknown | 7 | 24% |